Table 2.
Demographic information and clinical profiles of subjects used in this study.
| Case | Group | Age(y) | Sex | Clinical diagnosis or cause of death | Postmortem delay (h) |
Braak NFT stage |
Thal Aβ phase |
|---|---|---|---|---|---|---|---|
| 1 | Control | 76 | M | Heart stroke | 7 | 0 | 0 |
| 2 | Control | 78 | M | heart failure | 6 | I | 0 |
| 3 | Control | 80 | M | Iron-deficiency anemia | 7 | II | 0 |
| 4 | Control | 77 | M | Multisystem failure | 12 | III | 0 |
| 5 | Control | 81 | F | Chronic renal failure | 7 | IV | 0 |
| 6 | Control | 81 | M | Cardiovascular failure | 6 | II | 0 |
| 7 | Control | 78 | F | Ovary cancer | 4.5 | II | 0 |
| 8 | Control | 70 | F | Pneumonia | 12 | II | 0 |
| 9 | Aged/AD | 89 | M | Coronary heart | 8 | III | 1 |
| 10 | Aged/AD | 72 | M | Alzheimer’s disease (AD) | 8 | V | 4 |
| 11 | Aged/AD | 76 | M | Colon cancer | 5 | VI | C |
| 12 | Aged/AD | 74 | M | Multisystem failure | 5 | V | 5 |
| 13 | Aged/AD | 80 | M | Alzheimer’s disease (AD) | 22 | VI | 5 |
| 14 | Aged/AD | 76 | M | Chronic Heart Disease | 5 | VI | C |
| 15 | Aged/AD | 83 | F | Multisystem failure | 12 | III | 4 |
| 16 | Aged/AD | 85 | M | Astrocytoma | 12 | III | 4 |